SCHEMBL30145217

SCHEMBL30145217

COc1ccc(-c2cccn3cc(CC(N)=O)nc23)c(Cl)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A3 P47895 2/20 0.42
▸ HSP90AA1 P07900 1/20 0.40
▸ HSP90AB1 P08238 1/20 0.40
▸ PLA2G2A P14555 5/20 0.39
▸ HSD17B10 Q99714 2/20 0.38
▸ MAPT P10636 1/20 0.37
▸ CDC7 O00311 1/20 0.37
▸ CCNT1 O60563 1/20 0.37
▸ CSNK2A2 P19784 1/20 0.37
▸ CCNE1 P24864 1/20 0.37
▸ CDK2 P24941 1/20 0.37
▸ CSNK1A1 P48729 1/20 0.37
▸ CSNK1D P48730 1/20 0.37
▸ CDK9 P50750 1/20 0.37
▸ CSNK2B P67870 1/20 0.37
▸ CSNK2A1 P68400 1/20 0.37
▸ DBF4 Q9UBU7 1/20 0.37
▸ EIF4E P06730 1/20 0.37
▸ PPARG P37231 1/20 0.37
▸ KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30145295 0.91 ALDH1A3 (0.43) ALDH1A3HSP90AA1HSP90AB1HSD17B10MAPT
SCHEMBL20596557 0.87 MAPT (0.43) ALDH1A3HSD17B10MAPTCDC7DBF4
SCHEMBL20596534 0.83 LMNA (0.39) ALDH1A3HSP90AA1HSP90AB1MAPTCSNK1D
SCHEMBL30145335 0.75 MARS2 (0.43) HSP90AA1HSP90AB1PLA2G2AMAPTCDC7
SCHEMBL20595826 0.73 MARS2 (0.52) ALDH1A3HSP90AA1HSP90AB1PPARG
SCHEMBL30145166 0.73 MARS2 (0.52) ALDH1A3HSP90AA1HSP90AB1PPARG
SCHEMBL20595977 0.72 MARS2 (0.54) ALDH1A3HSP90AA1HSP90AB1PPARG
SCHEMBL30145251 0.72 MARS2 (0.54) ALDH1A3HSP90AA1HSP90AB1PPARG
SCHEMBL14736753 0.72 SMN1; SMN2 (0.57) HSD17B10MAPTKDM4EALDH1A1HPGD
SCHEMBL20596077 0.68 HSP90AA1 (0.39) HSP90AA1HSP90AB1HSD17B10MAPTCDC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11584744-B2 Inhibitors of type 1 methionyl-tRNA synthetase and methods of using them UNIVERSITY OF WASHINGTON (US) 2023-02-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11584744-B2 Inhibitors of type 1 methionyl-tRNA synthetase and methods of using them AARS1, EMG1, GARS1 ALDH1A3 1695/4885HSP90AA1 887/4885HSP90AB1 958/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback